NEWS

• Sygnature Discovery Unveils Strategic Rebrand To Cement Status As A Global Drug Discovery Partner

  Sygnature Discovery, a leading drug discovery contract research organisation (CRO), has today announced a strategic brand relaunch, including a new website, cementing its position as a global drug discovery partner.

• Suvoda Sets New Standard For Streamlined Patient And Site Experience In Clinical Trials

  Suvoda, a clinical trial technology company, took decisive steps in 2025 toward a more connected and streamlined clinical trial experience for both patients and sites. The company’s merger with Greenphire marked a pivotal moment in that journey, strengthening Suvoda’s ability to tackle persistent trial operational challenges with a more unified approach. Together with continued product innovation and deployment of AI tools, Suvoda closed the year with growing momentum toward a single, cohesive ecosystem that reduces complexity across the clinical trial lifecycle.

• Suvoda IRT Named A Leader In Everest Group's RTSM PEAK Matrix®

  Suvoda, a global clinical trial technology company, today announced that its IRT (Interactive Response Technology) software, also known as RTSM (Randomization and Trial Supply Management), has been recognized as a Leader in Everest Group’s PEAK Matrix® assessment for RTSM technology.

• Altasciences Announces Chris Perkin Appointed To Board Of Directors; Marie-Hélène Raigneau Appointed Chief Executive Officer

  Altasciences announced today that Chris Perkin has been appointed as a member of the company’s Board of Directors, effective Tuesday, February 24, 2026. Following a leadership transition that has been underway for the past 12 months, Marie-Hélène Raigneau, President of the company since April 2025, has been appointed Chief Executive Officer, also effective Tuesday, February 24, 2026.

• AI Agent Enhances Principal Investigator Oversight Of eCOA Data

  Explore how AI agents are better assisting principal investigators with oversight of electronic clinical outcome assessment (eCOA) data.

• Medable Debuts AI Agent for Automating Trial Master File (TMF) Processes

  Managing trial master files is often manual, time-consuming, and error-prone. Learn how AI agents can help automate TMF workflows and streamline clinical operations.

• Univo IRB And The Patient View Announce Partnership

  Univo IRB today announced a partnership with The Patient View to provide essential patient insights that will improve clinical trial participation and retention for sponsors and CROs.

• Avance Clinical Launches Diversity In STEM Scholarships Across Australia And North America

  Avance Clinical, the award-winning global CRO for biotechs, has announced the launch of its new Diversity in STEM Scholarships, a global initiative designed to support women and minority-group students pursuing careers in science, technology, engineering, and mathematics (STEM). The program includes dedicated intakes in Australia and the broader Asia-Pacific region, as well as North America, reinforcing the company’s commitment to equity and inclusion in clinical research.

• Lindus Health And Quotient Sciences Partner To Accelerate Drug Development From First-In-Human To Pivotal Trials

  Lindus Health and Quotient Sciences partnership combines Quotient's specialized early clinical and drug development capabilities with Lindus’ proven patient recruitment expertise and later-stage trial delivery.

• Integrating Lyft Healthcare As An Affordable On-Demand Transportation Provider For Clinical Trial Participants: A Move Towards Enhanced Patient Experience
• Yoncare s.r.o. Partners With Block Clinical Inc. To Deliver EU-Centric Clinical Trial Participant Travel And Payment Services In Europe
• Block Clinical Discusses Patient Travel Support With Panel Members
• Quotient Sciences And Intrepid Labs Form Strategic Partnership To Accelerate AI-Guided Formulation Development

  Under the new agreement, Quotient Sciences will have access to Intrepid’s machine learning model, ANDROMEDA, the first AI platform to develop and optimize clinical performance of drug products. The platform is designed to significantly reduce formulation development timelines, reduce API demands and increase formulation understanding, helping clients reach critical milestones faster and improve confidence in clinical success.

• One App To Simplify The Clinical Trial Journey

  Unified mobile app streamlines trial tasks—scheduling, questionnaires, travel, and reimbursements—reducing burden and improving engagement for patients and study teams.